The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
about
Genetic perspective on the role of the autophagy-lysosome pathway in Parkinson diseaseThe role of oxidative stress in Parkinson's diseaseOxidative stress-induced signaling pathways implicated in the pathogenesis of Parkinson's diseaseRisk of Parkinson's Disease in the Users of Antihypertensive Agents: An Evidence from the Meta-Analysis of Observational StudiesMorphological changes of glutamatergic synapses in animal models of Parkinson's diseaseInside-out neuropharmacology of nicotinic drugsMitochondrial dysfunction and oxidative stress in Parkinson's diseaseImmunomodulators as Therapeutic Agents in Mitigating the Progression of Parkinson's DiseaseNicotinamide, NAD(P)(H), and Methyl-Group Homeostasis Evolved and Became a Determinant of Ageing Diseases: Hypotheses and Lessons from PellagraAxon degeneration and PGC-1α-mediated protection in a zebrafish model of α-synuclein toxicityIonic currents influencing spontaneous firing and pacemaker frequency in dopamine neurons of the ventrolateral periaqueductal gray and dorsal raphe nucleus (vlPAG/DRN): A voltage-clamp and computational modelling study.Behavioral Senescence and Aging-Related Changes in Motor Neurons and Brain Neuromodulator Levels Are Ameliorated by Lifespan-Extending Reproductive Dormancy in Drosophila.Regulation of pyruvate metabolism and human disease2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is selectively toxic to primary dopaminergic neurons in vitroProtective effects of SKF-96365, a non-specific inhibitor of SOCE, against MPP+-induced cytotoxicity in PC12 cells: potential role of Homer1.Involvement of the sodium-calcium exchanger 3 (NCX3) in ziram-induced calcium dysregulation and toxicity.Inhibition of store-operated calcium entry attenuates MPP(+)-induced oxidative stress via preservation of mitochondrial function in PC12 cells: involvement of Homer1a.Mitochondrial Dysfunction and α-Synuclein Synaptic Pathology in Parkinson's Disease: Who's on First?NF-κB in Innate Neuroprotection and Age-Related Neurodegenerative Diseases.Parkinson's disease: don't mess with calcium.The antioxidant mechanisms underlying the aged garlic extract- and S-allylcysteine-induced protection.Mitochondrial mutations and polymorphisms in psychiatric disorders.A novel synthetic isothiocyanate ITC-57 displays antioxidant, anti-inflammatory, and neuroprotective properties in a mouse Parkinson's disease model.Involvement of heat shock proteins on Mn-induced toxicity in Caenorhabditis elegans.Human neuronal uncoupling proteins 4 and 5 (UCP4 and UCP5): structural properties, regulation, and physiological role in protection against oxidative stress and mitochondrial dysfunction.Late-onset Parkinsonism in NFκB/c-Rel-deficient miceSmoking-Relevant Nicotine Concentration Attenuates the Unfolded Protein Response in Dopaminergic Neurons.Impairment of PARK14-dependent Ca(2+) signalling is a novel determinant of Parkinson's diseaseQuantitation of hydrogen peroxide fluctuations and their modulation of dopamine dynamics in the rat dorsal striatum using fast-scan cyclic voltammetry.Calcium entry and α-synuclein inclusions elevate dendritic mitochondrial oxidant stress in dopaminergic neuronsAssociation between serum biochemical levels, related to bone metabolism and Parkinson's diseaseSOD2 in mitochondrial dysfunction and neurodegeneration.Zonisamide: a review of the clinical and experimental evidence for its use in Parkinson's diseaseComparative study of the neurotrophic effects elicited by VEGF-B and GDNF in preclinical in vivo models of Parkinson's disease.Activity-dependent regulation of the dopamine phenotype in substantia nigra neurons.Integrating pathways of Parkinson's disease in a molecular interaction map.In vitro dopaminergic neurotoxicity of pesticides: a link with neurodegeneration?The possible involvement of mitochondrial dysfunctions in Lewy body dementia: a systematic review.Alterations in the E3 ligases Parkin and CHIP result in unique metabolic signaling defects and mitochondrial quality control issues.Novel Dystonia Genes: Clues on Disease Mechanisms and the Complexities of High-Throughput Sequencing.
P2860
Q22242985-DBAA9D62-0D3B-4DC5-95DD-E7A5F3BC93C9Q24307946-97E9A6B1-CE7B-49B5-8858-9E5BB822FD49Q24337079-AFFAA5CA-C936-48BE-BA46-61F7D214C894Q26741763-231210ED-1888-470C-9E74-0D19744BF379Q26781619-3415872B-2FFE-4805-84C2-3C548FC7A44DQ27010347-CAB0F379-9949-4283-8D07-577DD064DD8BQ27014051-CB4C2BD2-91E2-4201-903E-FE155244BF11Q28079187-BB2CFE7E-DFE1-43E7-9541-1EF8275EAE3BQ28730781-04E8010F-0C39-4F80-9AF2-A6123D873E53Q30577415-BF5360B2-E410-43A7-BE75-F365E2FA7C40Q30846890-7C12D854-F572-4100-8D75-30CB5B462652Q30847227-B42118BC-AEB8-4B18-914E-F5D1B89B2437Q33764544-487CB235-4E42-4B6A-A833-62BFD9A8B906Q34048236-8F129375-4A47-4C5E-B82B-012FEB0D122CQ34576781-B5C4E327-1F7B-4700-BC2A-328D0941DD22Q34714298-AA81DD2C-EA93-468A-9658-62008D07E29EQ35073154-CD8423BB-1243-40F6-8475-714C8897AA75Q35412397-2143E08C-4E8D-4D19-AE36-9326C79EB033Q35627153-373F9C72-C416-42D5-B6BF-7A179ECF23E5Q35858158-C6159CB7-9A24-45F1-9546-1E2FAFA4D94EQ35997060-15E0143D-FDFA-41B1-A2EF-88CA33C72BEDQ36045522-D0425A77-5ADB-481F-87EE-B6EC47958BA0Q36123780-C6BE672F-7B89-45B9-B027-B9E387CFB3F7Q36179612-7B11929E-1EBA-4222-B389-73959AE1DC01Q36206017-C7B7DAC0-047D-4DF9-BAD6-6ABEB4489734Q36218699-FE2628E6-7EF2-4F5A-8D04-3773B1168A25Q36432022-4C6C443D-31A2-4A18-93B7-52E628A29DBCQ36511361-D8330C77-FFED-4170-82E3-597928F70298Q36851676-01E46851-619E-4B6B-AE7B-1EF5EB7809B6Q36928454-664CEFB0-935D-4039-8895-BC90D1CE53B0Q37095001-6B4469F9-4598-47AB-A6A1-586AE38570E6Q37262897-DFC65F24-60B5-43FE-8B33-50865EA11A5FQ37356891-D83A45B9-695E-4BA1-BE77-B243A9A0F325Q37582397-F84A9419-583F-48E4-8F34-5B8F65A62508Q37987187-59F0F319-243B-4A08-8481-F5F1240AE6C2Q38119873-AD9E43B8-F78D-4310-B308-B7937B428AABQ38288482-9A533850-38C6-4101-98B0-6A120BC76C5CQ38582520-1568E41F-A2F4-4AEE-AC25-D0AB9DB309FCQ38603276-EC999E0B-C9D7-4333-B11F-909480D88496Q38780028-8E14DAF6-ED04-4C36-8DDA-EAC001196C2E
P2860
The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
The role of calcium and mitoch ...... eurons in Parkinson's disease.
@ast
The role of calcium and mitoch ...... eurons in Parkinson's disease.
@en
type
label
The role of calcium and mitoch ...... eurons in Parkinson's disease.
@ast
The role of calcium and mitoch ...... eurons in Parkinson's disease.
@en
prefLabel
The role of calcium and mitoch ...... eurons in Parkinson's disease.
@ast
The role of calcium and mitoch ...... eurons in Parkinson's disease.
@en
P2093
P2860
P921
P1433
P1476
The role of calcium and mitoch ...... eurons in Parkinson's disease.
@en
P2093
D J Surmeier
J N Guzman
J Sanchez-Padilla
P T Schumacker
P2860
P304
P356
10.1016/J.NEUROSCIENCE.2011.08.045
P407
P577
2011-08-25T00:00:00Z